We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current CRBU market cap is 201.51M. The company's latest EPS is USD -1.1296 and P/E is -1.97.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Revenue | 3.76M | 23.66M | 3.56M | 2.43M | 3.46M |
| Operating Income | -32.87M | -14.63M | -37.45M | -46M | -43.5M |
| Net Income | -29.52M | -10M | -34.51M | -41.23M | -37.7M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 9.6M | 13.85M | 34.48M |
| Operating Income | -66.98M | -106.4M | -116.07M |
| Net Income | -66.92M | -99.42M | -102.07M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Assets | 349.65M | 457.52M | 432.21M | 406.83M | 372.94M |
| Total Liabilities | 80.19M | 59.25M | 63.81M | 63.54M | 62.47M |
| Total Equity | 269.46M | 398.27M | 368.4M | 343.29M | 310.46M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 442.36M | 373.77M | 432.21M |
| Total Liabilities | 54.53M | 72.89M | 63.81M |
| Total Equity | 387.83M | 300.87M | 368.4M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Operating | -43.12M | -71.91M | -93.29M | -37.2M | -70.07M |
| Investing | 31.77M | -36.71M | -68.18M | 22.96M | 44.16M |
| Financing | 19.21M | 154.34M | 154.3M | 12.49M | 12.62M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Operating | -32.52M | -90.97M | -93.29M |
| Investing | -176.4M | -93.25M | -68.18M |
| Financing | 433.43M | 2.13M | 154.3M |
| Market Cap | 201.51M |
| Price to Earnings Ratio | -1.97 |
| Price to Sales Ratio | 5.82 |
| Price to Cash Ratio | 3.92 |
| Price to Book Ratio | 0.54 |
| Dividend Yield | - |
| Shares Outstanding | 90.36M |
| Average Volume (1 week) | 1.55M |
| Average Volume (1 Month) | 880.96k |
| 52 Week Change | -38.57% |
| 52 Week High | 8.33 |
| 52 Week Low | 1.50 |
| Spread (Intraday) | 0.08 (3.59%) |
| Company Name | Caribou Biosciences Inc |
| Address |
3500 s dupont hwy dover, delaware 19901 |
| Website | https://www.cariboubio.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
